Literature DB >> 23230592

[Updated standards for the diagnosis and treatment of primary liver cancer].

.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23230592

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN： 1007-3418


× No keyword cloud information.
  15 in total

1.  Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.

Authors:  Haijian Zhang; Min Yao; Wei Wu; Liwei Qiu; Wenli Sai; Junling Yang; Wenjie Zheng; Jianfei Huang; Dengfu Yao
Journal:  Tumour Biol       Date:  2015-06-26

2.  Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma.

Authors:  Liuhong Pan; Min Yao; Wenjie Zheng; Juanjuan Gu; Xuli Yang; Liwei Qiu; Yin Cai; Wei Wu; Dengfu Yao
Journal:  Tumour Biol       Date:  2015-11-17

3.  Diagnostic and prognostic significance of secretory clusterin expression in patients with hepatocellular carcinoma.

Authors:  Wenjie Zheng; Min Yao; Wenli Sai; Qi Qian; Liuhong Pan; Liwei Qiu; Jianfei Huang; Wei Wu; Dengfu Yao
Journal:  Tumour Biol       Date:  2015-08-12

4.  Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma.

Authors:  Liu-Hong Pan; Min Yao; Yin Cai; Juan-Juan Gu; Xu-Li Yang; Li Wang; Deng-Fu Yao
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

5.  The hepatitis B virus reactivation after transarterial chemoembolization in Chinese hepatocellular carcinoma patients with low serum hepatitis B virus DNA level.

Authors:  Wenbo Shao; Fengjuan Zhang; Ning Cong; Jinpeng Li; Jinlong Song
Journal:  Ther Clin Risk Manag       Date:  2015-09-07       Impact factor: 2.423

Review 6.  Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion.

Authors:  Jian-Hong Zhong; A Chapin Rodríguez; Yang Ke; Yan-Yan Wang; Lin Wang; Le-Qun Li
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

7.  Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update).

Authors:  Jinlin Hou; Guiqiang Wang; Fusheng Wang; Jun Cheng; Hong Ren; Hui Zhuang; Jian Sun; Lanjuan Li; Jie Li; Qinghua Meng; Jingmin Zhao; Zhongping Duan; Jidong Jia; Hong Tang; Jifang Sheng; Jie Peng; Fengmin Lu; Qing Xie; Lai Wei
Journal:  J Clin Transl Hepatol       Date:  2017-11-12

8.  Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients.

Authors:  Tao Wu; Xiaojiao Zheng; Ming Yang; Aihua Zhao; Meng Li; Tianlu Chen; Jun Panee; Wei Jia; Guang Ji
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

9.  Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC.

Authors:  Yanyan Wei; Wei Ye; Wei Zhao
Journal:  Front Physiol       Date:  2018-02-06       Impact factor: 4.566

10.  Expression characteristics of KAI1 and vascular endothelial growth factor and their diagnostic value for hepatocellular carcinoma.

Authors:  Wu Zhang; Cheng Guang Zhao; Hong Yu Sun; Wei E Zheng; Hua Chen
Journal:  Gut Liver       Date:  2014-07-25       Impact factor: 4.519
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.